EMERYVILLE, Calif., April 4, 2014 (GLOBE NEWSWIRE) -- Amyris, Inc. (Nasdaq:AMRS), a leading synthetic biology innovator and renewable products company, today announced it has begun selling Biofene®, Amyris's brand of farnesene, a long-chain branched hydrocarbon, online at farnesene.net. By making initial quantities of its building block molecule available to a broader audience, Amyris seeks to expand Biofene's use beyond the commercial applications the Company and its partners are already developing.
"We want to make our renewable hydrocarbon building block molecule widely available to create new products and applications. We expect to accelerate Amyris's commercialization by simplifying access to high-purity, renewable farnesene," said John Melo, Amyris's President & CEO.
Amyris is now selling Biofene through its website in 1 kilogram lot sizes (about a quarter of a gallon). Biofene ( trans- beta -Farnesene, E,E-Farnesene, CAS 18794-84-8) is a 15 carbon, long-chain, branched, unsaturated hydrocarbon manufactured by the fermentation of plant-sugars using Amyris's engineered microbes." This innovative approach is complementary to our current strategy for growing existing products – such as our Neossance™ Squalane, renewable fuels, base oils and monomers for the tire industry, all of which are produced from our farnesene," concluded Melo. Biofene offers unique physical properties and chemical reactivity for new materials and for a variety of applications, including adhesives, surfactants, resins, coatings, vitamin precursors, performance materials and crop protection. Farnesene is an essential oil that is found in small quantities in some plants such as apples, but Amyris has developed a proprietary technology to produce farnesene at industrial scale. Visit farnesene.net today for additional information and special introductory pricing. About Amyris Amyris is an integrated renewable products company focused on providing sustainable alternatives to a broad range of petroleum-sourced products. Amyris uses its industrial synthetic biology platform to convert plant sugars into a variety of molecules -- flexible building blocks that can be used in a wide range of products. Amyris is commercializing these products both as No Compromise® renewable ingredients in cosmetics, flavors and fragrances, polymers, lubricants and consumer products, and also as No Compromise renewable diesel and jet fuel. Amyris Brasil Ltda., a subsidiary of Amyris, oversees the establishment and expansion of Amyris' production in Brazil. More information about Amyris is available at www.amyris.com . Forward-Looking Statements This release contains forward-looking statements, and any statements other than statements of historical facts could be deemed to be forward-looking statements. These forward-looking statements include, among other things, statements regarding future events ( such as expansion of commercial applications for Biofene, and creation of new products from, and acceleration of commercialization efforts for, Biofene) that involve risks and uncertainties. These statements are based on management's current expectations and actual results and future events may differ materially due to risks and uncertainties, including those associated with potential complications in the launch of a new product sales initiative, uncertainty regarding demand levels for Biofene, Amyris's reliance on third parties to achieve its goals, and other risks detailed in the "Risk Factors" section of Amyris' quarterly report on Form 10-K filed on April 2, 2014. Amyris disclaims any obligation to update information contained in these forward-looking statements whether as a result of new information, future events, or otherwise. Amyris, the Amyris logo, Biofene, Neossance, and No Compromise are trademarks or registered trademarks of Amyris, Inc.
CONTACT: Amyris, Inc. Media & Investor Relations firstname.lastname@example.org
Check Out Our Best Services for Investors
- $2.5+ million portfolio
- Large-cap and dividend focus
- Intraday trade alerts from Cramer
Access the tool that DOMINATES the Russell 2000 and the S&P 500.
- Buy, hold, or sell recommendations for over 4,300 stocks
- Unlimited research reports on your favorite stocks
- A custom stock screener
- Model portfolio
- Stocks trading below $10
- Intraday trade alerts